ArticleF&S reports2024

Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials.

James A Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.